pharma.markets

  • HOME
  • Imprint

merck

Merck Accelerates European Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies

17/03/2021 MaP 0

Merck will add a single-use assembly production unit at its Life Science Center in Molsheim, France. € 25 million investment in Molsheim, France, will create […]

Merck Brings New Renewable Energy to the Grid through Virtual Power Purchase Agreement with Enel Green Power

16/03/2021 MaP 0

Merck is an anchor buyer of a 12-year renewable energy contract for the Azure Sky wind and storage project in Texas, United States 68 megawatts […]

Biden Administration Announces Historic Manufacturing Collaboration Between Merck and Johnson & Johnson to Expand Production of COVID-19 Vaccines

03/03/2021 MaP 0

President Biden Invokes Defense Production Act to Support Measures to Accelerate Vaccine Development President Biden announced today that his Administration has helped forge a historic […]

Merck Enhances Design for Sustainability Framework, Offers Customers Data-Driven Insights for Greener Solutions

15/02/2021 MaP 0

Merck has launched an enhanced Design for Sustainability (DfS) framework, a unique approach to holistically integrate sustainability into Life Science products, systems and services. Merck, […]

Merck strengthens site in Tempe, Arizona as key strategic production and R&D hub

09/02/2021 MaP 0

…for semiconductor materials in the United States Merck today announced an investment of €18 million at its site in Tempe, Arizona, USA • Purchase of […]

Merck Mourns Hans Joachim Langmann

09/02/2021 MaP 0

Professor Hans Joachim Langmann, former Chairman of the Executive Board of Merck, died on February 6, 2021 at the age of 96. Hans Joachim Langmann […]

Merck and BioNTech Extend Strategic Partnership Through Accelerated Supply of Urgently Needed Lipids

05/02/2021 MaP 0

Merck, in close collaboration with BioNTech, will significantly accelerate the supply of urgently needed lipids and increase the amount of lipid delivery towards the end […]

Merck Continues Commitment to Science Education and Equity with Leading Non-Profits Around the World

05/02/2021 MaP 0

Building on its commitment to accelerate scientific research and science education, Merck has announced seven expanded partnerships with leading nonprofit organizations across the world. Building […]

Merck Announces Leadership Change for North America and Global Innovative Medicine Franchises in Healthcare

05/02/2021 MaP 0

Merck today announced that Rehan Verjee has made the decision to leave his position as President of EMD Serono and Global Head of Innovative Medicine […]

FDA Approves TEPMETKO® as the First and Only Once-daily Oral MET Inhibitor

03/02/2021 MaP 0

….for Patients with Metastatic NSCLC with METex14 Skipping Alterations Merck today announced that the US Food and Drug Administration (FDA) has approved TEPMETKO® (tepotinib) following […]

Merck Announces Formation of Merck Digital Ethics Advisory Panel

08/01/2021 MaP 0

Designed to provide guidance around evolving digital business models, the panel will address digital ethics questions for all three business sectors of Merck. Merck, a […]

Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics

07/01/2021 MaP 0

Merck today announced the acquisition of AmpTec a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO). • Adds to Merck’s lipid manufacturing expertise, […]

Posts navigation

1 2 »

Translation

en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianja Japaneseko Koreanpt Portugueseru Russianes Spanish

Search

Categories

  • Age.related Degeneration
  • Animal health
  • Asthma
  • Cancer
  • COVID-19
  • EIB
  • EU
  • FCPA Investigations
  • FDA
  • Finance
  • HHS
  • Humanitarian Aid
  • Imprint
  • Influenza
  • MS
  • News
  • Research
  • Rheumatology
  • Space Science
  • UN
  • Vaccines
  • Valencia Comunidad

Reports

  • Pfizer and BioNTech Request Regulatory Agencies Expand Emergency Use of Their COVID-19 Vaccine to Adolescents
  • Spain – The vaccination schedule: when will we be vaccinated?
  • Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months
  • IPS Selected by Apiject as a Key Partner for Greenfield Blow−Fill−Seal Aseptic Manufacturing Campus
  • BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site

Archive

  • April 2021 (3)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • Pfizer and BioNTech Request Regulatory Agencies Expand Emergency Use of Their COVID-19 Vaccine to Adolescents

    09/04/2021 0
  • Spain – The vaccination schedule: when will we be vaccinated?

    07/04/2021 0
  • Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months

    01/04/2021 0
  • IPS Selected by Apiject as a Key Partner for Greenfield Blow−Fill−Seal Aseptic Manufacturing Campus

    30/03/2021 0
  • BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site

    26/03/2021 0
Archives
  • April 2021 (3)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid biontech cancer commission companies coronavirus covid-19 covid19 crisis economy elpais.com eu europe european fda fight food global guarantee health hygiene italy links medical merck pandemic pfizer production products recommendations region response roche safety scheme sector spain state statistics stats support test vaccine

Copyright © 2021 | WordPress Theme by MH Themes